Role Of Fdg Pet-ct In Evaluation Of Gastrointestinal Stromal Tumors
-
- Englisch ausgewählt
Fr. 51.90
inkl. gesetzl. MwSt.,
Beschreibung
Produktdetails
Einband
Taschenbuch
Erscheinungsdatum
10.07.2017
Verlag
LAP LAMBERT Academic PublishingSeitenzahl
72
Maße (L/B/H)
22/15/0.5 cm
Gewicht
125 g
Sprache
Englisch
ISBN
978-3-330-32612-5
Gastrointestinal stromal tumors (GISTs) are the most frequent mesenchymal tumors of the gastrointestinal tract. A definition of a new entity among the gastrointestinal mesenchymal tumors called the gastrointestinal stromal tumors (GISTs) which express the kit (CD117) protein a growth factor trans-membrane receptor with tyrosine kinase activity. Surgery is the mainstay of therapy for non-metastatic GISTs. The c-kit tyrosine kinase inhibitor Imatinib (Glivec), was found to be useful in treating GISTs, leading to a 40-70% response rate in metastatic or inoperable cases.The current Response Evaluation Criteria in solid tumors are based on uni-dimensional tumor size, and do not take into account changes in responding GISTs such as a decrease in tumor density and decrease in the number of intra-tumoral vessels with CT. PET/CT is highly sensitive in assessment early response to Imatinib mesylate. Also, it is useful in predicting long-term response to imatinib in patients with metastatic GIST; however, widespread use of PET is limited because of cost constraints.
Noch keine Bewertungen vorhanden
Verfassen Sie die erste Bewertung zu diesem Artikel
Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.